Lung Cancer: Chaired by Jason Porter, MD
Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.
Speakers:
- Jason Porter, MD | West Cancer Center & Research Institute
- Wade T. Iams, MD | Vanderbilt-Ingram Cancer Center
- Ramakrishna Battini, MD | West Cancer Center & Research Institute
- David C. Portnoy, MD, FACP | West Cancer Center & Research Institute
Topics:
- Frontline SCLC
- Second Line SCLC
- Targeting EGFR in Lung Cancer
- Other Targetable Alterations (RET, METex14, BRAF, HER2)